Analysis: Pharma's woes not over, more restructuring seen

According to pharmaceutical market information company IMS Health, four large pharma companies -- AstraZeneca, Lilly, Boehringer Ingelheim and Bayer AG -- as of the end of 2009, had progressed less than one-third of the way through the patent cliff that...